ReShape Lifesciences Inc. (RSLS) EPS is poised to hit -0.20 next quarter: How Investors Can Make It Count the Most?

0
14

ReShape Lifesciences Inc. (NASDAQ: RSLS) flaunted slowness of -8.10% at $0.16, as the Stock market unbolted on November 23, 2022. During the day, the stock rose to $0.18 and sunk to $0.1484 before settling in for the price of $0.17 at the close. Taking a more long-term approach, RSLS posted a 52-week range of $0.15-$2.22.


Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report

Sponsored


The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 32.00%. Meanwhile, its Annual Earning per share during the time was 32.80%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -4.60%. This publicly-traded company’s shares outstanding now amounts to $24.18 million, simultaneously with a float of $22.59 million. The organization now has a market capitalization sitting at $3.78 million. At the time of writing, stock’s 50-day Moving Average stood at $0.2866, while the 200-day Moving Average is $0.6664.

Let’s gauge the efficiency of the firm, which has a total of 47 employees. For the Profitability, stocks gross margin was +61.38, operating margin was -187.12 and Pretax Margin of -456.17.

ReShape Lifesciences Inc. (RSLS) Ownership Facts and Figures

Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the ReShape Lifesciences Inc. industry. ReShape Lifesciences Inc.’s current insider ownership accounts for 4.60%, in contrast to 3.30% institutional ownership. According to the most recent insider trade that took place on Nov 04, this organization’s Chief Financial Officer sold 8,393 shares at the rate of 0.27, making the entire transaction reach 2,287 in total value, affecting insider ownership by 332,761. Preceding that transaction, on Oct 04, Company’s CFO sold 8,293 for 0.28, making the whole transaction’s value amount to 2,329. This particular insider is now the holder of 338,670 in total.

ReShape Lifesciences Inc. (RSLS) Earnings and Revenue Records

Going through the last 3-months fiscal report unveiled on the 6/29/2022, it has been observed that the corporation posted -$0.5 earnings per share (EPS) during the time that was less the consensus figure (set at -$0.36) by -$0.14. This company achieved a net margin of -455.39 while generating a return on equity of -244.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year.

ReShape Lifesciences Inc.’s EPS decrease for this current 12-month fiscal period is -4.60% and is forecasted to reach -0.51 in the upcoming year.

ReShape Lifesciences Inc. (NASDAQ: RSLS) Trading Performance Indicators

Let’s observe the current performance indicators for ReShape Lifesciences Inc. (RSLS). It’s Quick Ratio in the last reported quarter now stands at 1.70. The Stock has managed to achieve an average true range (ATR) of 0.03. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.31.

In the same vein, RSLS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.40, a figure that is expected to reach -0.20 in the next quarter, and analysts are predicting that it will be -0.51 at the market close of one year from today.

Technical Analysis of ReShape Lifesciences Inc. (RSLS)

Now, what If we examine the latest scores posted by [ReShape Lifesciences Inc., RSLS]. During the last 5-days, its volume was better the volume of 0.26 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 11.68% While, its Average True Range was 0.0334.

LEAVE A REPLY

Please enter your comment!
Please enter your name here